Larry Kimsey, MD
Psychiatry · Caldwell, IDNPI 1528022084
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 46.7% of the total.
Across 21 payments — averaging $36.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$358
- Johnson & Johnson$123
- Sunovion Pharmaceuticals Inc.$73
- Eisai Inc.$71
- AbbVie$54
- Alkermes, Inc.$48
- plus $41 from 2 others
What the payments were for
- Food & beverage$767100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $358 |
| Johnson & Johnson | 2 | $123 |
| Sunovion Pharmaceuticals Inc. | 2 | $73 |
| Eisai Inc. | 4 | $71 |
| AbbVie | 1 | $54 |
| Alkermes, Inc. | 3 | $48 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$114
- ABILIFY ASIMTUFII$112
- ABILIFY MAINTENA$112
- REXULTI$111
How this compares
$767 in reported general payments places this provider in the 80th percentile of 98 psychiatry providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 30 | $8,220 |
| Clomipramine Hcl | 40 | $7,167 |
| Lurasidone Hcl | 33 | $5,772 |
| Quetiapine Fumarate | 118 | $4,225 |
| Lamotrigine | 201 | $1,896 |
| Fluvoxamine Maleate | 34 | $1,821 |
| Trazodone Hcl | 155 | $1,493 |
| Escitalopram Oxalate | 168 | $1,450 |
| Divalproex Sodium ErDivalproex Sodium | 44 | $1,229 |
| Bupropion Hcl SrBupropion Hcl | 60 | $1,083 |
| Clonazepam | 143 | $1,063 |
| Clorazepate Dipotassium | 17 | $981 |
| Duloxetine Hcl | 55 | $958 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 27 | $945 |
| Bupropion XlBupropion Hcl | 69 | $898 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Caldwell
- Lawrence BantaCaldwell$3K
- Colt KenningtonCaldwell$1K
- Sandra LareCaldwell$791
- Alfred BremCaldwell$590
- Richard MontgomeryCaldwell$305
- Craig DennyIdaho Falls$10K
- Linda CarterPocatello$9K
- Janet GilbreathNampa$9K
- Olurotimi AshayeMeridian$8K
- Thomas HolmesLewiston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.